The well-characterized CaMBP neurogranin (Ng, RCE, p17, BICKS) is not only a useful biomarker for AD, but also for PD, as well as Creutzfeldt–Jakob disease and other brain diseases [45]. This evidence concerns the gene NRGN and Alzheimer disease.